Key Statistics for SCMP
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SCMP
- Net Income (M/USD)
Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.
More Company Profile & Key Executives for SCMP
|Ryuji UenoChairman/CEO/Co-Founder||Cary J ClaiborneChief Financial Officer|
|Thomas J KnappExec VP/Chief Legal Ofcr/Secy||Stanley G MieleSenior VP:Sales & Marketing|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.